Filtered By:
Source: European Journal of Heart Failure
Condition: Heart Failure
This page shows you your search results in order of relevance. This is page number 7.
Order by Relevance | Date
Total 113 results found since Jan 2013.
Association Between HbA1c Levels and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Cardiovascular Disease: A Secondary Analysis of the TECOS Randomized Clinical Trial
ConclusionHbA1c exhibits a U ‐shaped association with cardiovascular outcomes in patients with T2D and atherosclerotic vascular disease, with nadir around 7%.This article is protected by copyright. All rights reserved.
Source: European Journal of Heart Failure - July 3, 2020 Category: Cardiology Authors: Finlay A. McAlister,
Yinggan Zheng,
Cynthia M. Westerhout,
John B. Buse,
Eberhard Standl,
Darren K. McGuire,
Frans Van de Werf,
Jennifer B. Green,
Paul W. Armstrong,
Rury R. Holman,
on behalf of
the TECOS Study Group Tags: Research Article Source Type: research
Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial
ConclusionGlycated haemogobin exhibits a U ‐shaped association with cardiovascular outcomes in patients with T2D and atherosclerotic vascular disease, with nadir around 7%.Clinical Trial Registration: ClinicalTrials.gov Identifier: NCT00790205.
Source: European Journal of Heart Failure - July 27, 2020 Category: Cardiology Authors: Finlay A. McAlister,
Yinggan Zheng,
Cynthia M. Westerhout,
John B. Buse,
Eberhard Standl,
Darren K. McGuire,
Frans Van de Werf,
Jennifer B. Green,
Paul W. Armstrong,
Rury R. Holman,
TECOS Study Group Tags: Research Article Source Type: research
Relationship between body mass index, cardiovascular biomarkers and incident heart failure
ConclusionsPlasma concentrations of several cardiovascular biomarkers are influenced by obesity. Only NT ‐proBNP, MR‐proANP and cTnT were associated with incident HF, and BMI did not modify these associations. A combination of NT‐proBNP and cTnT improves HF risk prediction in overweight and obese individuals.
Source: European Journal of Heart Failure - February 8, 2021 Category: Cardiology Authors: Navin Suthahar,
Laura M.G. Meems,
Dion Groothof,
Stephan J.L. Bakker,
Ron T. Gansevoort,
Dirk J. Veldhuisen,
Rudolf A. Boer Tags: Short Report Source Type: research
Use of sodium –glucose co‐transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry
ConclusionIn a contemporary HF cohort with T2DM, SGLT2i use increased over time, was more common with specialist care, younger age, ischaemic heart disease, and preserved renal function, and was associated with lower mortality and morbidity.
Source: European Journal of Heart Failure - March 3, 2021 Category: Cardiology Authors: Peter M. Becher,
Benedikt Schrage,
Giulia Ferrannini,
Lina Benson,
Javed Butler,
Juan Jesus Carrero,
Francesco Cosentino,
Ulf Dahlstr öm,
Linda Mellbin,
Giuseppe M.C. Rosano,
Gianfranco Sinagra,
Davide Stolfo,
Lars H. Lund,
Gianluigi Savares Tags: Research Article Source Type: research
Hemodynamic Effects of the Nitroxyl Donor Cimlanod (BMS ‐986231) in Chronic Heart Failure: A Randomized Trial
ConclusionIn patients with chronic HFrEF, the hemodynamic effects of cimlanod and NTG are similar. The effects of cimlanod may be explained by venodilatation and preload reduction without additional inotropic or lusitropic effects. Ongoing trials of cimlanod will further define its potential role in the treatment of heart failure.
Source: European Journal of Heart Failure - February 23, 2021 Category: Cardiology Authors: Ninian N. Lang,
Faheem A. Ahmad,
John G. Cleland,
Christopher M. O'Connor,
John R. Teerlink,
Adriaan A. Voors,
Jorg Taubel,
Anke R. Hodes,
Mohamed Anwar,
Ravi Karra,
Yasushi Sakata,
Shiro Ishihara,
Roxy Senior,
Abhishek Khemka,
Narayana G. P Tags: Research Article Source Type: research
Use of sodium –glucose co‐transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry
ConclusionIn a contemporary HF cohort with T2DM, SGLT2i use increased over time, was more common with specialist care, younger age, ischaemic heart disease, and preserved renal function, and was associated with lower mortality and morbidity.
Source: European Journal of Heart Failure - March 3, 2021 Category: Cardiology Authors: Peter M. Becher,
Benedikt Schrage,
Giulia Ferrannini,
Lina Benson,
Javed Butler,
Juan Jesus Carrero,
Francesco Cosentino,
Ulf Dahlstr öm,
Linda Mellbin,
Giuseppe M.C. Rosano,
Gianfranco Sinagra,
Davide Stolfo,
Lars H. Lund,
Gianluigi Savares Tags: Research Article Source Type: research
Relationship between body mass index, cardiovascular biomarkers and incident heart failure
ConclusionsPlasma concentrations of several cardiovascular biomarkers are influenced by obesity. Only NT ‐proBNP, MR‐proANP and cTnT were associated with incident HF, and BMI did not modify these associations. A combination of NT‐proBNP and cTnT improves HF risk prediction in overweight and obese individuals.
Source: European Journal of Heart Failure - February 8, 2021 Category: Cardiology Authors: Navin Suthahar,
Laura M.G. Meems,
Dion Groothof,
Stephan J.L. Bakker,
Ron T. Gansevoort,
Dirk J. Veldhuisen,
Rudolf A. Boer Tags: Short Report Source Type: research
Primary Results of Long ‐Term Outcomes in the MOMENTUM 3 Pivotal Trial and Continued Access Protocol Study Phase: A Study of 2200 HeartMate 3 Left Ventricular Assist Device Implants
ConclusionsThe primary results of accumulating HM3 LVAD experience suggest a lower adverse event burden and similar survival compared to the pivotal MOMENTUM 3 trial.This article is protected by copyright. All rights reserved.
Source: European Journal of Heart Failure - May 1, 2021 Category: Cardiology Authors: Mandeep R. Mehra,
Joseph C. Cleveland,
Nir Uriel,
Jennifer A. Cowger,
Shelley Hall,
Douglas Horstmanshof,
Yoshifumi Naka,
Christopher T. Salerno,
Joyce Chuang,
Christopher Williams,
Daniel J. Goldstein,
on behalf of the MOMENTUM 3 Investigators Tags: Research Article Source Type: research
Relationship between body mass index, cardiovascular biomarkers and incident heart failure
ConclusionsPlasma concentrations of several cardiovascular biomarkers are influenced by obesity. Only NT-proBNP, MR-proANP and cTnT were associated with incident HF, and BMI did not modify these associations. A combination of NT-proBNP and cTnT improves HF risk prediction in overweight and obese individuals.
Source: European Journal of Heart Failure - April 29, 2021 Category: Cardiology Authors: Navin Suthahar,
Laura M.G. Meems,
Dion Groothof,
Stephan J.L. Bakker,
Ron T. Gansevoort,
Dirk J. van Veldhuisen,
Rudolf A. de Boer Tags: Short report Source Type: research
Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC Peripartum Cardiomyopathy Registry
ConclusionDifferences exist in phenotype, recovery of cardiac function and neonatal outcomes according to hypertensive status in women with PPCM.
Source: European Journal of Heart Failure - June 11, 2021 Category: Cardiology Authors: Alice M Jackson,
Mark C Petrie,
Alexandra Frogoudaki,
C écile Laroche,
Finn Gustafsson,
Bassem Ibrahim,
Alexandre Mebazaa,
Mark R Johnson,
Petar M Seferovic,
Vera Regitz‐Zagrosek,
Amam Mbakwem,
Michael Böhm,
Hawani Sasmaya Prameswari,
Doa Tags: Research Article Source Type: research
Stopping mineralocorticoid receptor antagonists after hyperkalemia: trial emulation in data from routine care
ConclusionsStopping MRA after an episode of hyperkalemia was associated with reduced risk for recurrent hyperkalemia, but higher risk of death or cardiovascular events. Recurrent hyperkalemia was common in either strategy.
Source: European Journal of Heart Failure - July 1, 2021 Category: Cardiology Authors: Marco Trevisan,
Biostat Edouard L. Fu,
Yang Xu,
Gianluigi Savarese,
Friedo W Dekker,
Lars H Lund,
Catherine M Clase,
Arvid Sj ölander Biostat,
Juan Jesus Carrero Tags: Research Article Source Type: research
Vericiguat in Patients with Atrial Fibrillation and Heart Failure with Reduced Ejection Fraction: Insights from the VICTORIA trial
ConclusionsAF was present in nearly half of this high-risk population with worsening HF. A history of AF alone at baseline portends an increased risk of cardiovascular death. Neither type of AF affected the beneficial effect of vericiguat. Development of AF post-randomization was associated with an increase in both cardiovascular death and HF hospitalization which was not influenced by vericiguat.This article is protected by copyright. All rights reserved.
Source: European Journal of Heart Failure - June 30, 2021 Category: Cardiology Authors: Piotr Ponikowski,
Wendimagegn Alemayehu,
Ali Oto,
M. Cecilia Bahit,
Ebrahim Noori,
Mahesh J. Patel,
Javed Butler,
Justin A. Ezekowitz,
Adrian F. Hernandez,
Carolyn S.P. Lam,
Christopher M. O'Connor,
Burkert Pieske,
Lothar Roessig,
Adriaan A. Tags: Research Article Source Type: research
Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care
ConclusionsStopping MRA after an episode of hyperkalaemia was associated with reduced risk for recurrent hyperkalaemia, but higher risk of death or cardiovascular events. Recurrent hyperkalaemia was common in either strategy.
Source: European Journal of Heart Failure - July 19, 2021 Category: Cardiology Authors: Marco Trevisan,
Edouard L. Fu,
Yang Xu,
Gianluigi Savarese,
Friedo W. Dekker,
Lars H. Lund,
Catherine M. Clase,
Arvid Sj ölander,
Juan J. Carrero Tags: Research Article Source Type: research
Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry
ConclusionDifferences exist in phenotype, recovery of cardiac function and neonatal outcomes according to hypertensive status in women with PPCM.
Source: European Journal of Heart Failure - August 26, 2021 Category: Cardiology Authors: Alice M. Jackson,
Mark C. Petrie,
Alexandra Frogoudaki,
C écile Laroche,
Finn Gustafsson,
Bassem Ibrahim,
Alexandre Mebazaa,
Mark R. Johnson,
Petar M. Seferovic,
Vera Regitz‐Zagrosek,
Amam Mbakwem,
Michael Böhm,
Hawani S. Prameswari,
Doaa Tags: Research Article Source Type: research
